FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 44 filers reported holding FINCH THERAPEUTICS GROUP INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $472,946 | -27.7% | 55,445 | -96.7% | 1.27% | -60.7% |
| Q1 2023 | $653,703 | -18.1% | 1,663,366 | 0.0% | 3.23% | +74.4% |
| Q4 2022 | $798,416 | -71.3% | 1,663,366 | 0.0% | 1.85% | -60.8% |
| Q3 2022 | $2,778,000 | -41.2% | 1,663,366 | 0.0% | 4.72% | -41.5% |
| Q2 2022 | $4,724,000 | -43.5% | 1,663,366 | 0.0% | 8.08% | +5.6% |
| Q1 2022 | $8,367,000 | -49.5% | 1,663,366 | 0.0% | 7.65% | -13.9% |
| Q4 2021 | $16,584,000 | – | 1,663,366 | – | 8.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|